Ferring Pharmaceuticals successfully launches its inaugural Swiss Franc Bond offering for an amount of CHF 270 million
in PRESS RELEASE 2020 on
Ferring Pharmaceuticals successfully launches its inaugural Swiss Franc Bond offering for an…
0
0
-
Read more
-
“Standing together against injustice” – a message from Per Falk, President and Chief Science Officer at Ferring
in STATEMENT 2021 onRead more“Standing together against injustice” – a message from Per Falk, President and…
-
Ferring and Igenomix collaborate to advance care in reproductive medicine and maternal health
in PRESS RELEASE 2020 onRead moreFerring Pharmaceuticals and Igenomix today announced a two-year research collaboration aimed at the discovery of novel targets and disease mechanisms in infertility and pregnancy-related conditions, including preeclampsia, with the goal of developing innovative diagnostic and therapeutic strategies in these areas of high unmet need.
-
Ferring Statement on the COVID-19 (novel coronavirus disease) Pandemic and Reproductive Medicine
in STATEMENT 2020 onRead moreThe health and safety of our patients, our employees and their families are Ferring’s number one priority. As the situation regarding COVID-19 (novel coronavirus disease) is evolving rapidly, Ferring is committed to following appropriate global, regional and local medical authority guidance to prevent infection spread and to keep patients, our employees and their families safe.